Published in

Elsevier, The Lancet, 10411(402), p. 1449-1458, 2023

DOI: 10.1016/s0140-6736(23)01583-0

Links

Tools

Export citation

Search in Google Scholar

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Journal article published in 2023 by Arshad M. Khanani, Sunil S. Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J. Danzig, David A. Eichenbaum, Jason Hsu, Charles C. Wykoff, Jeffrey S. Heier, David R. Lally, Jordi Monés, Jared S. Nielsen, Veeral S. Sheth, Peter K. Kaiser, Julie Clark and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO